Reich SG, Savitt JM (2019) Parkinson’s disease. Med Clin N Am 103(2):337–350. https://doi.org/10.1016/j.mcna.2018.10.014. (Epub 2019/02/02)
Hirtz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhuri AR, Zalutsky R (2007) How common are the “common” neurologic disorders? Neurology 68(5):326–337. https://doi.org/10.1212/01.wnl.0000252807.38124.a3. (Epub 2007/01/31)
Article CAS PubMed Google Scholar
Dorsey ER, Elbaz A, Nichols E, Abbasi N, Abd-Allah F, Abdelalim A, Adsuar JC, Ansha MG, Brayne C, Choi JY, Collado-Mateo D (2018) Global, regional, and national burden of Parkinson’s disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17(11):939–953. https://doi.org/10.1016/s1474-4422(18)30295-3. (Epub 2018/10/06)
Ben-Shlomo Y, Darweesh S, Llibre-Guerra J, Marras C, San Luciano M, Tanner C (2024) The epidemiology of Parkinson’s disease. Lancet (London, England). 403(10423):283–292. https://doi.org/10.1016/s0140-6736(23)01419-8. (Epub 2024/01/21)
Chen Y, Sun X, Lin Y, Zhang Z, Gao Y, Wu IXY (2021) Non-genetic risk factors for Parkinson’s disease: an overview of 46 systematic reviews. J Parkinson’s Dis. 11(3):919–935. https://doi.org/10.3233/jpd-202521. (Epub 2021/04/06)
Li X, Wang W, Yan J, Zeng F (2021) Glutamic acid transporters: targets for neuroprotective therapies in Parkinson’s disease. Front Neurosci 15:678154. https://doi.org/10.3389/fnins.2021.678154. (Epub 2021/07/06)
Santiago JA, Potashkin JA (2023) Physical activity and lifestyle modifications in the treatment of neurodegenerative diseases. Front Aging Neurosci. 15:1185671. https://doi.org/10.3389/fnagi.2023.1185671. (Epub 2023/06/12)
Article CAS PubMed Google Scholar
Reichmann H, Csoti I, Koschel J, Lorenzl S, Schrader C, Winkler J et al (2022) Life style and Parkinson’s disease. J Neural Transm (Vienna, Austria: 1996). 129(9):1235–1245. https://doi.org/10.1007/s00702-022-02509-1. (Epub 2022/05/24)
World Health Organization (WHO) (2018). Physical activity: World Health Organisation; 2022 [30 March,2024]. https://www.who.int/news-room/fact-sheets/detail/physical-activity.
Slomski A (2022) Even low amounts of physical activity reduce depression risk. JAMA 327(21):2066. https://doi.org/10.1001/jama.2022.8997. (Epub 2022/06/08)
Kunutsor SK, Seidu S, Mäkikallio TH, Dey RS, Laukkanen JA (2021) Physical activity and risk of atrial fibrillation in the general population: meta-analysis of 23 cohort studies involving about 2 million participants. Eur J Epidemiol 36(3):259–274. https://doi.org/10.1007/s10654-020-00714-4. (Epub 2021/01/26)
Luo M, Yu C, Del Pozo CB, Chen L, Ding D (2023) Accelerometer-measured intensity-specific physical activity, genetic risk and incident type 2 diabetes: a prospective cohort study. Br J Sports Med 57(19):1257–1264. https://doi.org/10.1136/bjsports-2022-106653. (Epub 2023/06/06)
Pedersen BK, Saltin B (2015) Exercise as medicine - evidence for prescribing exercise as therapy in 26 different chronic diseases. Scand J Med Sci Sports 25(Suppl 3):1–72. https://doi.org/10.1111/sms.12581. (Epub 2015/11/26)
Sasco AJ, Paffenbarger RS Jr, Gendre I, Wing AL (1992) The role of physical exercise in the occurrence of Parkinson’s disease. Arch Neurol 49(4):360–365. https://doi.org/10.1001/archneur.1992.00530280040020. (Epub 1992/04/11)
Article CAS PubMed Google Scholar
Xu Q, Park Y, Huang X, Hollenbeck A, Blair A, Schatzkin A et al (2010) Physical activities and future risk of Parkinson disease. Neurology 75(4):341–348. https://doi.org/10.1212/WNL.0b013e3181ea1597. (Epub 2010/07/28)
Article CAS PubMed Google Scholar
Fan B, Jabeen R, Bo B, Guo C, Han M, Zhang H et al (2020) What and how can physical activity prevention function on Parkinson’s disease? Oxid Med Cell Longev 2020:4293071. https://doi.org/10.1155/2020/4293071. (Epub 2020/03/28)
Mak MK, Wong-Yu IS, Shen X, Chung CL (2017) Long-term effects of exercise and physical therapy in people with Parkinson disease. Nat Rev Neurol 13(11):689–703. https://doi.org/10.1038/nrneurol.2017.128. (Epub 2017/10/14)
Schootemeijer S, van der Kolk NM, Bloem BR, de Vries NM (2020) Current perspectives on aerobic exercise in people with Parkinson’s disease. Neurotherapeutics 17(4):1418–1433. https://doi.org/10.1007/s13311-020-00904-8. (Epub 2020/08/19)
Shulman LM, Katzel LI, Ivey FM, Sorkin JD, Favors K, Anderson KE et al (2013) Randomized clinical trial of 3 types of physical exercise for patients with Parkinson disease. JAMA Neurol 70(2):183–190. https://doi.org/10.1001/jamaneurol.2013.646. (Epub 2012/11/07)
Speelman AD, van de Warrenburg BP, van Nimwegen M, Petzinger GM, Munneke M, Bloem BR (2011) How might physical activity benefit patients with Parkinson disease? Nat Rev Neurol 7(9):528–534. https://doi.org/10.1038/nrneurol.2011.107. (Epub 2011/07/14)
Liu HH, Yeh NC, Wu YF, Yang YR, Wang RY, Cheng FY (2019) Effects of Tai Chi exercise on reducing falls and improving balance performance in Parkinson’s disease: a meta-analysis. Parkinson’s Dis. 2019:9626934. https://doi.org/10.1155/2019/9626934. (Epub 2019/03/29)
Fang X, Han D, Cheng Q, Zhang P, Zhao C, Min J et al (2018) Association of levels of physical activity with risk of Parkinson disease: a systematic review and meta-analysis. JAMA Netw Open 1(5):e182421. https://doi.org/10.1001/jamanetworkopen.2018.2421. (Epub 2019/01/16)
Portugal B, Artaud F, Degaey I, Roze E, Fournier A, Severi G et al (2023) Association of physical activity and parkinson disease in women: long-term follow-up of the E3N cohort study. Neurology 101(4):e386–e398. https://doi.org/10.1212/wnl.0000000000207424. (Epub 2023/05/18)
Article CAS PubMed Google Scholar
An JH, Han KD, Jung JH, Jeon HJ (2023) Association of physical activity with the risk of Parkinson’s disease in depressive disorder: a nationwide longitudinal cohort study. J Psychiatr Res 167:93–99. https://doi.org/10.1016/j.jpsychires.2023.10.022. (Epub 2023/10/21)
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev 10(1):89. https://doi.org/10.1186/s13643-021-01626-4. (Epub 2021/03/31)
Wells GA, Shea D, O’Connell D, Peterson J, Welch V, Losos M. The newcastle-ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses 2011 [30 March,2024]. https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 30 Mar 2024
Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J et al (2011) GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 64(4):383–394. https://doi.org/10.1016/j.jclinepi.2010.04.026. (Epub 2011/01/05)
Ioannidis JP (2009) Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses. CMAJ Can Med Assoc J J l’Assoc Med Can. 181(8):488–493. https://doi.org/10.1503/cmaj.081086. (Epub 2009/08/06)
Greenland S, Thomas DC, Morgenstern H (1986) The rare-disease assumption revisited. A critique of “estimators of relative risk for case-control studies.” Am J Epidemiol 124(6):869–883. https://doi.org/10.1093/oxfordjournals.aje.a114476. (Epub 1986/12/01)
Article CAS PubMed Google Scholar
Tsai CH, Lo SK, See LC, Chen HZ, Chen RS, Weng YH et al (2002) Environmental risk factors of young onset Parkinson’s disease: a case-control study. Clin Neurol Neurosurg 104(4):328–333. https://doi.org/10.1016/s0303-8467(02)00027-6. (Epub 2002/07/26)
Article CAS PubMed Google Scholar
Kyrozis A, Ghika A, Stathopoulos P, Vassilopoulos D, Trichopoulos D, Trichopoulou A (2013) Dietary and lifestyle variables in relation to incidence of Parkinson’s disease in Greece. Eur J Epidemiol 28(1):67–77. https://doi.org/10.1007/s10654-012-9760-0. (Epub 2013/02/05)
Yang XL, Luo Q, Song HX, Wang YL, Yao YN, Xia H (2015) Related factors and prevalence of Parkinson’s disease among Uygur residents in Hetian, Xinjiang Uygur Autonomous Region. Genet Mol Res GMR. 14(3):8539–8546. https://doi.org/10.4238/2015.July.31.1. (Epub 2015/09/09)
留言 (0)